Dr. Imecca Akpa is a Glendale, Arizona based psychologist who is specialized in Clinical Psychology. Her current practice location is 4425 W Olive Ave Ste 151, Glendale. Patients can reach her at 602-456-4817. Dr. Imecca Akpa is PSY.D. in Clinical Psychology and her NPI number (Unique professional ID assigned by NPPES) is 1699306431. Dr. Imecca Akpa is a mental health professional with highly specialized training in the diagnosis and psychological treatment of mental, behavioral and emotional illnesses, including obsessive-compulsive disorder (OCD). Her main focus is on diagnosing and treating mental, emotional, and behavioral disorders. Some of the common disorders that she can treat are learning disabilities, substance abuse, depression, anxiety, and eating disorders.
Complete Profile:
Dr. Imecca Akpa speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Dr. Imecca Akpa
Specialization:
Clinical Psychology
Gender:
Female
Credentials:
PSY.D.
Practice Address:
4425 W Olive Ave Ste 151, Glendale, Arizona, 85302-3855
Phone:
602-456-4817
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1699306431
NPI Enumeration Date:
30 Jan, 2020
NPI Last Update On:
12 Apr, 2020
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Imecca Akpa 4425 W Olive Ave Ste 151, Glendale, Arizona
Zip:
85302-3855
Phone Number:
602-456-4817
Patients can reach Dr. Imecca Akpa at 4425 W Olive Ave Ste 151, Glendale, Arizona or can call to book an appointment on 602-456-4817.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.